The Technical AnalystExchange: EURONEXT Industry: Drug Manufacturers General Specialty & Generic
Fagron NV Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.53% €18.78
America/New_York / 17 mai 2024 @ 11:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 370.69 mill |
| EPS: | 0.970 |
| P/E: | 19.36 |
| Earnings Date: | Aug 01, 2024 |
| SharesOutstanding: | 72.99 mill |
| Avg Daily Volume: | 0.0576 mill |
| RATING 2024-05-17 |
|---|
| S |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Buy | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.10x |
| Company: PE 19.36 | sector: PE 17.68 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.67x |
| Company: PE 19.36 | industry: PE 11.60 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€41.36 (120.26%) €22.58 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
€ 18.47 - 19.09 ( +/- 1.63%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €18.78 (-0.53% ) |
| Volume | 0.0398 mill |
| Avg. Vol. | 0.0576 mill |
| % of Avg. Vol | 69.04 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For FAGR.BR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
FAGR.BR
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.